Literature DB >> 25242323

H3K36 histone methyltransferase Setd2 is required for murine embryonic stem cell differentiation toward endoderm.

Yuanliang Zhang1, Shugao Xie1, Yan Zhou1, Yinyin Xie1, Ping Liu1, Mingming Sun2, Huasheng Xiao2, Ying Jin3, Xiaojian Sun1, Zhu Chen1, Qiuhua Huang4, Saijuan Chen5.   

Abstract

Setd2 is known as a histone-H3K36-specific methyltransferase. However, its role in physiological function remains unclear. In this study, we show that Setd2 mainly regulates differentiation of murine embryonic stem cells (mESCs) toward primitive endoderm. Furthermore, we show that downregulated endoderm-related genes in Setd2(-/-) mESCs are associated with an aberrantly low level of Erk activity and that enforced expression of Fgfr3 can rescue the defective Erk pathway in Setd2(-/-) mESCs. Interestingly, the transcriptional initiation of Fgfr3 is directly regulated through histone H3K36me3 modification in its distal promoter region by Setd2. These results indicate that Setd2 controls the primitive endoderm differentiation of mESCs by regulating the Fgfr3-Erk signaling.
Copyright © 2014 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25242323     DOI: 10.1016/j.celrep.2014.08.031

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  34 in total

1.  Whsc1 links pluripotency exit with mesendoderm specification.

Authors:  Tian V Tian; Bruno Di Stefano; Grégoire Stik; Maria Vila-Casadesús; José Luis Sardina; Enrique Vidal; Alessandro Dasti; Carolina Segura-Morales; Luisa De Andrés-Aguayo; Antonio Gómez; Johanna Goldmann; Rudolf Jaenisch; Thomas Graf
Journal:  Nat Cell Biol       Date:  2019-06-24       Impact factor: 28.824

Review 2.  SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation.

Authors:  Catherine C Fahey; Ian J Davis
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

3.  H3K36 methylation state and associated silencing mechanisms.

Authors:  Shota Suzuki; Yota Murakami; Shinya Takahata
Journal:  Transcription       Date:  2016-10-10

4.  Acquired SETD2 mutation and impaired CREB1 activation confer cisplatin resistance in metastatic non-small cell lung cancer.

Authors:  In-Kyu Kim; Justine N McCutcheon; Guanhua Rao; Stephen V Liu; Yves Pommier; Marcin Skrzypski; Yu-Wen Zhang; Giuseppe Giaccone
Journal:  Oncogene       Date:  2018-08-09       Impact factor: 9.867

5.  Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.

Authors:  Huairui Yuan; Ni Li; Da Fu; Jiale Ren; Jingyi Hui; Junjie Peng; Yongfeng Liu; Tong Qiu; Min Jiang; Qiang Pan; Ying Han; Xiaoming Wang; Qintong Li; Jun Qin
Journal:  J Clin Invest       Date:  2017-08-21       Impact factor: 14.808

6.  SETD7 Drives Cardiac Lineage Commitment through Stage-Specific Transcriptional Activation.

Authors:  Jaecheol Lee; Ning-Yi Shao; David T Paik; Haodi Wu; Hongchao Guo; Vittavat Termglinchan; Jared M Churko; Youngkyun Kim; Tomoya Kitani; Ming-Tao Zhao; Yue Zhang; Kitchener D Wilson; Ioannis Karakikes; Michael P Snyder; Joseph C Wu
Journal:  Cell Stem Cell       Date:  2018-03-01       Impact factor: 24.633

Review 7.  Critical roles of protein methyltransferases and demethylases in the regulation of embryonic stem cell fate.

Authors:  Theodore Vougiouklakis; Yusuke Nakamura; Vassiliki Saloura
Journal:  Epigenetics       Date:  2018-01-16       Impact factor: 4.528

8.  Disabled homolog 2 is required for migration and invasion of prostate cancer cells.

Authors:  Yinyin Xie; Yuanliang Zhang; Lu Jiang; Mengmeng Zhang; Zhiwei Chen; Dan Liu; Qiuhua Huang
Journal:  Front Med       Date:  2015-07-05       Impact factor: 4.592

Review 9.  The Biogenesis and Precise Control of RNA m6A Methylation.

Authors:  Huilin Huang; Hengyou Weng; Jianjun Chen
Journal:  Trends Genet       Date:  2019-12-04       Impact factor: 11.639

10.  Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.

Authors:  Yuan-Liang Zhang; Jie-Wen Sun; Yin-Yin Xie; Yan Zhou; Ping Liu; Jia-Chun Song; Chun-Hui Xu; Lan Wang; Dan Liu; Ai-Ning Xu; Zhu Chen; Sai-Juan Chen; Xiao-Jian Sun; Qiu-Hua Huang
Journal:  Cell Res       Date:  2018-03-12       Impact factor: 25.617

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.